Brief: China Regenerative Medicine International enters into a collaboration agreement

China Regenerative Medicine International

23/09/2016 11:59

Sept 23 (Reuters) - China Regenerative Medicine 
International Ltd  8158.HK  
    * Entered into a collaboration agreement with University Of 
Hong Kong ("HKU") and Innovation And Technology Commission of 
HKSAR 
    * Estimated cost of project is approximately hk$8.8 million 
    * Pursuant to collaboration agreement, co shall hold all 
intellectual property rights arouse from project in its sole 
name 
 
Source (http://bit.ly/2cqmyUV) 
Further company coverage:  8158.HK  
 
 ((Bangalore.newsroom@thomsonreuters.com;))